AGI Therapeutics plc's Board
of Directors currently comprises four Non-Executive
Directors, including a Non-Executive Chairman,
and three Executive Directors. These individuals
bring a wealth of experience in the pharmaceutical,
financial and investment industry environments.
 |
Ronan
Lambe PhD, Non-Executive Chairman |
|
John
Devane Ph.D, Chief Executive Officer |
|
Mary
Martin Ph.D, Chief Operating Officer |
|
David
Young, Ph.D, President, US Operations |
|
David
Kelly, Chief Financial Officer |
|
Patrick
Ashe, Senior Vice President, Business Development |
|
Chris
Blackwell PhD, Non-Executive Director |
|
Frank
Kenny, Non-Executive Director |
|
Peter
Sandys, Non-Executive Director |
|
John
O' Sullivan, Non-Executive Director |
|
|
